Thrombophilia and retinal vascular occlusion

Charles J Glueck1, Robert K Hutchins, Joel Jurantee

  • 1Cholesterol Center, Jewish Hospital of Cincinnati, Cincinnati, OH, USA.

Insights

Thrombophilia, particularly high homocysteine, is linked to retinal vascular occlusions (CRVO, CRAO, AF). Treatment with vitamins normalized homocysteine in most patients, suggesting a treatable cause for these conditions.

Area of Science:

  • Ophthalmology
  • Hematology
  • Vascular Medicine

Background:

  • Retinal vascular occlusions, including central retinal vein occlusion (CRVO), central retinal artery occlusion (CRAO), and amaurosis fugax (AF), can lead to vision loss.
  • Thrombophilia, a condition characterized by an increased tendency to form blood clots, is a potential risk factor for these occlusive events.

Purpose of the Study:

  • To investigate the association between thrombophilia and CRVO, CRAO, and AF.
  • To assess the effectiveness of normalizing elevated homocysteine levels.
  • To examine the role of estrogen therapy in women who develop these conditions and have underlying thrombophilia.

Main Methods:

  • A case-control study involving 132 CRVO, 15 CRAO, and 17 AF cases compared to 105 healthy controls.
  • Thrombophilia-hypofibrinolysis measures were assessed in all participants.
  • Cardiovascular disease risk factors were compared between cases and controls.

Main Results:

  • CRVO cases showed higher rates of elevated homocysteine, anticardiolipin IgM, and Factor VIII compared to controls.
  • CRAO-AF cases had increased prevalence of high homocysteine and lupus anticoagulant.
  • Four CRVO cases and one CRAO case occurred after estrogen therapy initiation in women with thrombophilia.
  • Vitamin therapy (folic acid, B6, B12) normalized homocysteine in 81% of CRVO cases and 100% of CRAO-AF cases.

Conclusions:

  • Treatable thrombophilias, especially hyperhomocysteinemia, are more prevalent in patients with retinal vascular occlusions than in the general population.
  • Retinal vascular occlusions can occur in women using estrogens or estrogen agonists who have underlying thrombophilia.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...